Literature Highlights
Infographics summarizing COVID-19 research on diagnosis, risk factors, treatment, and more.
Each week, we provide COVID-19 research article summaries and the main highlights in an infographic. Please come back weekly for more updated pandemic infographic highlights covering diagnosis, risk factors, treatment, and more.
The Effect of Nirmatrelvir-Ritonavir on Viral Clearance and Length of Hospital Stay in Patients Infected with SARS-CoV-2 Omicron variants
Projected COVID-19 Mortality Reduction From Paxlovid Rollout
Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients
Antibody evasion properties of SARS-CoV-2 Omicron sublineages
Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States, March 1, 2020–June 28, 2021
Long‑Term Complications of COVID‑19 Infection in Adolescents and Children
Phase 2 safety and antiviral activity of SAB-185, a novel polyclonal antibody therapy for non-hospitalized adults with COVID-19
Reasons for Recieving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults — United States, November 1–December 10, 2022
A Randomized, Placebo-Controlled Pilot Study of Upamostat, a Host-Directed Serine Protease Inhibitor, for Outpatient Treatment of COVID-19
REsCue trial: Randomized controlled clinical trial with extended-release calcifediol in symptomatic COVID-19 outpatients
Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial
